Skip to content

DexCom DXCM Long-term investments

Long-term investments at other companies

Veracyte logo
VeracyteVCYT
$50.31M
Bit Digital logo
Bit DigitalBTBT
$1M
Kopin logo
KopinKOPN
$100K-88.9%
Cass Information Systems logo
Cass Information SystemsCASS
$209.42M+0.6%
Postal Realty Trust logo
Postal Realty TrustPSTL
$748.16M+21.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$14.7M-54.3%

Other financials

Income statement

See full
Revenue$1.3B+13.1%
Gross profit$830.0M+20.5%
Operating income$318.3M+49.7%
Net income$249.1M+38.5%
EPS (diluted)$0.64+42.2%

Balance sheet

See full
Cash & equivalents$1.1B-4.8%
Total debt$103.3M-23.1%
Total equity$2.6B+1.9%
Total assets$6.5B-11.9%

Cash flow

See full
Operating cash flow$525.6M+186%
CapEx$76.6M-12.0%
Free cash flow$449.0M+364%

Valuation

See full
Market cap$28.88B-17.6%
Enterprise value$27.88B-18.0%
P/E28.9×-32.4×
P/S5.8×-2.3×

Profitability

See full
Gross margin62.5%+3.7pp
Operating margin22.9%+6.9pp
Net margin20.1%+6.8pp
FCF margin29.7%+15.8pp

Returns & leverage

See full
Return on equity38.5%+15.7pp
Debt / equity0.0×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's long-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DexCom's long-term investments?
DexCom (DXCM) reported long-term investments of $212.2M in Q1 2026.
What does long-term investments mean?
Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.